Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 348 Results
Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected Territories
September 6, 2017
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on February 9, 2017
February 9, 2017
Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda™
February 3, 2017
Palatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda™
January 10, 2017
Palatin Technologies Closes on $16.5 Million Financing
December 7, 2016
Page 21 of 35